Advanced search
Publication Cover
Molecular and Cellular Biology Volume 19, 1999 - Issue 9
Submit an article Journal homepage
32
Views
199
CrossRef citations to date
0
Altmetric
Transcriptional Regulation

The Androgen Receptor Amino-Terminal Domain Plays a Key Role in p160 Coactivator-Stimulated Gene Transcription

Philippe Alen1 Division of Biochemistry
,
Frank Claessens1 Division of Biochemistry
,
Guido Verhoeven2 Laboratory for Experimental Medicine and Endocrinology, Faculty of Medicine, University of Leuven, B-3000Leuven, Belgium
,
Wilfried Rombauts1 Division of Biochemistry
&
Ben Peeters1 Division of BiochemistryCorrespondence[email protected]
Pages 6085-6097 | Received 31 Mar 1999, Accepted 11 May 1999, Published online: 27 Mar 2023

Citations (199)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (13)

Vida Firouzi, Parnaz Borjian Boroujeni, Zeinab Rokhsat Talab, Maryam Mohammadi, Mohammad Ali Sadighi Gilani, Marjan Sabbaghian & Anahita Mohseni Meybodi. (2019) Possible role of androgen receptor gene in therapeutic response of infertile men with hypogonadotropic hypogonadism. Systems Biology in Reproductive Medicine 65:4, pages 326-332.
Read now
Xuqing Zhang & Zhihua Sui. (2013) Deciphering the selective androgen receptor modulators paradigm. Expert Opinion on Drug Discovery 8:2, pages 191-218.
Read now
Tommi H Nyrönen & Annu A Söderholm. (2010) Structural basis for computational screening of non-steroidal androgen receptor ligands. Expert Opinion on Drug Discovery 5:1, pages 5-20.
Read now
Hongliang Zong, Yayun Chi, Yanlin Wang, Yanzhong Yang, Li Zhang, Haijiao Chen, Jianhai Jiang, Zejuan Li, Yi Hong, Hanzhou Wang, Xiaojing Yun & Jianxin Gu. (2007) Cyclin D3/CDK11p58 Complex Is Involved in the Repression of Androgen Receptor. Molecular and Cellular Biology 27:20, pages 7125-7142.
Read now
Yin Wu, Hisaya Kawate, Keizo Ohnaka, Hajime Nawata & Ryoichi Takayanagi. (2006) Nuclear Compartmentalization of N-CoR and Its Interactions with Steroid Receptors. Molecular and Cellular Biology 26:17, pages 6633-6655.
Read now
Scott Segal, Ramesh Narayanan & James T Dalton. (2006) Therapeutic potential of the SARMs: revisiting the androgen receptor for drug discovery. Expert Opinion on Investigational Drugs 15:4, pages 377-387.
Read now
Javid Javidan, Arline D. Deitch, Xu-Bao Shi & Ralph W. de Vere White. (2005) The Androgen Receptor and Mechanisms for Androgen Independence in Prostate Cancer. Cancer Investigation 23:6, pages 520-528.
Read now
Keiko Hosohata, Peng Li, Yoshiaki Hosohata, Jun Qin, Robert G. Roeder & Zhengxin Wang. (2003) Purification and Identification of a Novel Complex Which Is Involved in Androgen Receptor-Dependent Transcription. Molecular and Cellular Biology 23:19, pages 7019-7029.
Read now
Mario Maira, Christine Martens, éric Batsché, Yves Gauthier & Jacques Drouin. (2003) Dimer-Specific Potentiation of NGFI-B (Nur77) Transcriptional Activity by the Protein Kinase A Pathway and AF-1-Dependent Coactivator Recruitment. Molecular and Cellular Biology 23:3, pages 763-776.
Read now
Suzanne E. Wardell, Viroj Boonyaratanakornkit, James S. Adelman, Ami Aronheim & Dean P. Edwards. (2002) Jun Dimerization Protein 2 Functions as a Progesterone Receptor N-Terminal Domain Coactivator. Molecular and Cellular Biology 22:15, pages 5451-5466.
Read now
Maofu Fu, Chenguang Wang, Jian Wang, Xueping Zhang, Toshiyuki Sakamaki, Y. G. Yeung, Chawnshang Chang, Torsten Hopp, Suzanne A. W. Fuqua, Ellis Jaffray, Ron T. Hay, Jorma J. Palvimo, Olli A. Jänne & Richard G. Pestell. (2002) Androgen Receptor Acetylation Governs trans Activation and MEKK1-Induced Apoptosis without Affecting In Vitro Sumoylation and trans-Repression Function. Molecular and Cellular Biology 22:10, pages 3373-3388.
Read now
Yunsheng Ren, Evan Behre, Zhaojun Ren, Jiachang Zhang, Qianben Wang & Joseph D. Fondell. (2000) Specific Structural Motifs Determine TRAP220 Interactions with Nuclear Hormone Receptors. Molecular and Cellular Biology 20:15, pages 5433-5446.
Read now
. (1999) Abstracts of the Belgian Association of Biochemistry and Molecular Biology, 172nd Reunion, Namur (FUNDP), 8th May 1999. Archives of Physiology and Biochemistry 107:5, pages 403-427.
Read now

Articles from other publishers (186)

Javier Pozas, Sara Álvarez Rodríguez, Víctor Albarrán Fernández, Javier Burgos, Matteo Santoni, Ray Manneh Kopp, Javier Molina-Cerrillo & Teresa Alonso-Gordoa. (2022) Androgen Receptor Signaling Inhibition in Advanced Castration Resistance Prostate Cancer: What Is Expected for the Near Future?. Cancers 14:24, pages 6071.
Crossref
Sarah El Kharraz, Vanessa Dubois, Kaisa-Mari Launonen, Laura Helminen, Jorma J Palvimo, Claude Libert, Elien Smeets, Lisa Moris, Roy Eerlings, Dirk Vanderschueren, Christine Helsen & Frank Claessens. (2022) N/C Interactions Are Dispensable for Normal In Vivo Functioning of the Androgen Receptor in Male Mice. Endocrinology 163:9.
Crossref
Christine Helsen, Tien Nguyen, Thomas Vercruysse, Staf Wouters, Dirk Daelemans, Arnout Voet & Frank Claessens. (2022) The T850D Phosphomimetic Mutation in the Androgen Receptor Ligand Binding Domain Enhances Recruitment at Activation Function 2. International Journal of Molecular Sciences 23:3, pages 1557.
Crossref
Tanggang Deng, Yugang Xiao, Yi Dai, Lin Xie & Xiong Li. (2021) Roles of Key Epigenetic Regulators in the Gene Transcription and Progression of Prostate Cancer. Frontiers in Molecular Biosciences 8.
Crossref
Sarah El Kharraz, Vanessa Dubois, Martin E van Royen, Adriaan B Houtsmuller, Ekatarina Pavlova, Nina Atanassova, Tien Nguyen, Arnout Voet, Roy Eerlings, Florian Handle, Stefan Prekovic, Elien Smeets, Lisa Moris, Wout Devlies, Claes Ohlsson, Matti Poutanen, Kevin J Verstrepen, Geert Carmeliet, Kaisa‐Mari Launonen, Laura Helminen, Jorma J Palvimo, Claude Libert, Dirk Vanderschueren, Christine Helsen & Frank Claessens. (2021) The androgen receptor depends on ligand‐binding domain dimerization for transcriptional activation. EMBO reports 22:12.
Crossref
Donald J. AbrahamMichael L. Mohler & James T. Dalton. 2003. Burger's Medicinal Chemistry and Drug Discovery. Burger's Medicinal Chemistry and Drug Discovery 1 103 .
Wout Devlies, Markus Eckstein, Alessia Cimadamore, Gaëtan Devos, Lisa Moris, Thomas Van den Broeck, Rodolfo Montironi, Steven Joniau, Frank Claessens & Thomas Gevaert. (2020) Clinical Actionability of the Genomic Landscape of Metastatic Castration Resistant Prostate Cancer. Cells 9:11, pages 2494.
Crossref
Xinzhe Yu, Ping Yi, Ross A. Hamilton, Hong Shen, Muyuan Chen, Charles E. Foulds, Michael A. Mancini, Steven J. Ludtke, Zhao Wang & Bert W. O’Malley. (2020) Structural Insights of Transcriptionally Active, Full-Length Androgen Receptor Coactivator Complexes. Molecular Cell 79:5, pages 812-823.e4.
Crossref
Sirin Saranyutanon, Sanjeev Kumar Srivastava, Sachin Pai, Seema Singh & Ajay Pratap Singh. (2019) Therapies Targeted to Androgen Receptor Signaling Axis in Prostate Cancer: Progress, Challenges, and Hope. Cancers 12:1, pages 51.
Crossref
Florian Handle & Frank Claessens. (2019) AR variants: lost in translation to clinical practice?. Nature Reviews Urology 16:8, pages 451-452.
Crossref
Irene I Lee, Nane C Kuznik, Jaice T Rottenberg, Myles Brown & Andrew C B Cato. (2019) BAG1L: a promising therapeutic target for androgen receptor-dependent prostate cancer. Journal of Molecular Endocrinology 62:4, pages R289-R299.
Crossref
Pao-Lin Kuo, Jie-Yun Tseng, Hau-Inh Chen, Chia-Yun Wu, Hany A. Omar, Chia-Yih Wang, Han-Yi Cheng, Chao-Chin Hsu, Tzu-Fun Fu & Yen-Ni Teng. (2019) Identification of SEPTIN12 as a novel target of the androgen and estrogen receptors in human testicular cells. Biochimie 158, pages 1-9.
Crossref
Ramesh Narayanan, Christopher C. Coss & James T. Dalton. (2018) Development of selective androgen receptor modulators (SARMs). Molecular and Cellular Endocrinology 465, pages 134-142.
Crossref
Jianyun Zhang, Rui Liu, Lili Niu, Siyu Zhu, Quan Zhang, Meirong Zhao, Weiping Liu & Jing Liu. (2018) Determination of endocrine-disrupting potencies of agricultural soils in China via a battery of steroid receptor bioassays. Environmental Pollution 234, pages 846-854.
Crossref
C Flaveny, M Kumar & G.H. Perdew. 2018. Comprehensive Toxicology. Comprehensive Toxicology 55 75 .
Marco Marcelli. 2017. Testosterone. Testosterone 21 73 .
Stefan Prekovic, Martin E. van Royen, Arnout R.D. Voet, Bart Geverts, Rene Houtman, Diana Melchers, Kam Y.J. Zhang, Thomas Van den Broeck, Elien Smeets, Lien Spans, Adriaan B. Houtsmuller, Steven Joniau, Frank Claessens & Christine Helsen. (2016) The Effect of F877L and T878A Mutations on Androgen Receptor Response to Enzalutamide. Molecular Cancer Therapeutics 15:7, pages 1702-1712.
Crossref
Parth K. Modi, Izak Faiena & Isaac Yi Kim. 2016. Prostate Cancer. Prostate Cancer 21 28 .
Päivi Pihlajamaa, Biswajyoti Sahu & Olli A. Jänne. (2015) Determinants of Receptor- and Tissue-Specific Actions in Androgen Signaling. Endocrine Reviews 36:4, pages 357-384.
Crossref
Vanessa Dubois, Christine Helsen, Liesbeth Clinckemalie, Lien Spans, Michaël Laurent, Leen Antonio, Thomas Van den Broeck, Stefan Prekovic, Steven Joniau, Dirk Vanderschueren & Frank Claessens. 2015. Nuclear Receptors: From Structure to the Clinic. Nuclear Receptors: From Structure to the Clinic 59 72 .
Alessandro Didonna & Puneet Opal. (2014) The promise and perils of HDAC inhibitors in neurodegeneration . Annals of Clinical and Translational Neurology 2:1, pages 79-101.
Crossref
Donita J. Africander, Karl-Heinz Storbeck & Janet P. Hapgood. (2014) A comparative study of the androgenic properties of progesterone and the progestins, medroxyprogesterone acetate (MPA) and norethisterone acetate (NET-A). The Journal of Steroid Biochemistry and Molecular Biology 143, pages 404-415.
Crossref
Jonathan A.G. Mackinnon, Nerea Gallastegui, David J. Osguthorpe, Arnold T. Hagler & Eva Estébanez-Perpiñá. (2014) Allosteric mechanisms of nuclear receptors: insights from computational simulations. Molecular and Cellular Endocrinology 393:1-2, pages 75-82.
Crossref
Alexander Endler, Li Chen & Futoshi Shibasaki. (2014) Coactivator Recruitment of AhR/ARNT1. International Journal of Molecular Sciences 15:6, pages 11100-11110.
Crossref
Katja Jehle, Laura Cato, Antje Neeb, Claudia Muhle-Goll, Nicole Jung, Emmanuel W. Smith, Victor Buzon, Laia R. Carbó, Eva Estébanez-Perpiñá, Katja Schmitz, Ljiljana Fruk, Burkhard Luy, Yu Chen, Marc B. Cox, Stefan Bräse, Myles Brown & Andrew C.B. Cato. (2014) Coregulator Control of Androgen Receptor Action by a Novel Nuclear Receptor-binding Motif. Journal of Biological Chemistry 289:13, pages 8839-8851.
Crossref
Avani Atul Shah, William Figg & William Dahut. (2014) Challenges in overcoming hormonal resistance in prostate cancer. Clinical Investigation 4:2, pages 153-162.
Crossref
Ken-ichi Takayama & Satoshi Inoue. (2013) Transcriptional network of androgen receptor in prostate cancer progression. International Journal of Urology 20:8, pages 756-768.
Crossref
Chen Pan, Ya-Peng Liu, Yan-Fang Li, Jin-Xia Hu, Jin-Peng Zhang, Hong-Mei Wang, Jing Li & Li-Chun Xu. (2012) Effects of cypermethrin on the ligand-independent interaction between androgen receptor and steroid receptor coactivator-1. Toxicology 299:2-3, pages 160-164.
Crossref
Sathish Kasina & Jill A. Macoska. (2012) The CXCL12/CXCR4 axis promotes ligand-independent activation of the androgen receptor. Molecular and Cellular Endocrinology 351:2, pages 249-263.
Crossref
Dennis J. van de Wijngaart, Hendrikus Jan Dubbink, Martin E. van Royen, Jan Trapman & Guido Jenster. (2012) Androgen receptor coregulators: Recruitment via the coactivator binding groove. Molecular and Cellular Endocrinology 352:1-2, pages 57-69.
Crossref
Feng Jin, Frank Claessens & Joseph D. Fondell. (2012) Regulation of Androgen Receptor-dependent Transcription by Coactivator MED1 Is Mediated through a Newly Discovered Noncanonical Binding Motif. Journal of Biological Chemistry 287:2, pages 858-870.
Crossref
Christine Helsen, Stefanie Kerkhofs, Liesbeth Clinckemalie, Lien Spans, Michaël Laurent, Steven Boonen, Dirk Vanderschueren & Frank Claessens. (2012) Structural basis for nuclear hormone receptor DNA binding. Molecular and Cellular Endocrinology 348:2, pages 411-417.
Crossref
Shayne Cox GadGregory T. Wurz & Michael W. DeGregorio. 2010. Pharmaceutical Sciences Encyclopedia. Pharmaceutical Sciences Encyclopedia.
Scott M Dehm & Donald J Tindall. (2011) Alternatively spliced androgen receptor variants. Endocrine-Related Cancer 18:5, pages R183-R196.
Crossref
Ryan L. Sheppard, Espen E. Spangenburg, Eva R. Chin & Stephen M. Roth. (2011) Androgen receptor polyglutamine repeat length affects receptor activity and C2C12 cell development. Physiological Genomics 43:20, pages 1135-1143.
Crossref
Grant Buchanan, Eleanor F. Need, Jeffrey M. Barrett, Tina Bianco-Miotto, Vanessa C. Thompson, Lisa M. Butler, Villis R. Marshall, Wayne D. Tilley & Gerhard A. Coetzee. (2011) Corepressor effect on androgen receptor activity varies with the length of the CAG encoded polyglutamine repeat and is dependent on receptor/corepressor ratio in prostate cancer cells. Molecular and Cellular Endocrinology 342:1-2, pages 20-31.
Crossref
Zhihao Wang, Bo Yang, Lanlan Dong, Biwen Peng, Xiaohua He & Wanhong Liu. (2011) A novel oncoprotein Pirh2: rising from the shadow of MDM2. Cancer Science 102:5, pages 909-917.
Crossref
Dennis J. van de Wijngaart, Hendrikus J. Dubbink, Michel Molier, Carola de Vos, Guido Jenster & Jan Trapman. (2011) Inhibition of androgen receptor functions by gelsolin FxxFF peptide delivered by transfection, cell-penetrating peptides, and lentiviral infection. The Prostate 71:3, pages 241-253.
Crossref
Laura Davies, Elissavet Paraskevopoulou, Malihah Sadeq, Christiana Symeou, Constantia Pantelidou, Constantinos Demonacos & Marija Krstic-Demonacos. (2011) Regulation of Glucocorticoid Receptor Activity by a Stress Responsive Transcriptional Cofactor. Molecular Endocrinology 25:1, pages 58-71.
Crossref
Abhijit M. Godbole & Vincent C. O. Njar. (2011) New Insights into the Androgen-Targeted Therapies and Epigenetic Therapies in Prostate Cancer. Prostate Cancer 2011, pages 1-13.
Crossref
Reinhilde De Bruyn, Rita Bollen & Frank Claessens. 2011. Androgen Action. Androgen Action 81 93 .
Maria Papaioannou, Sonja Schleich, Daniela Roell, Undine Schubert, Tamzin Tanner, Frank Claessens, Rudolf Matusch & Aria Baniahmad. (2009) NBBS isolated from Pygeum africanum bark exhibits androgen antagonistic activity, inhibits AR nuclear translocation and prostate cancer cell growth. Investigational New Drugs 28:6, pages 729-743.
Crossref
X. Edward Zhou, Kelly M. Suino-Powell, Jun Li, Yuanzheng He, Jeffrey P. MacKeigan, Karsten Melcher, Eu-Leong Yong & H. Eric Xu. (2010) Identification of SRC3/AIB1 as a Preferred Coactivator for Hormone-activated Androgen Receptor. Journal of Biological Chemistry 285:12, pages 9161-9171.
Crossref
C. Flaveny, M. Kumar & G.H. Perdew. 2010. Comprehensive Toxicology. Comprehensive Toxicology 183 206 .
Edward P. Gelmann. 2010. Drug Management of Prostate Cancer. Drug Management of Prostate Cancer 61 70 .
Sung Bae Kim, Yoshio Umezawa & Hiroaki Tao. (2009) Determination of the Androgenicity of Ligands Using a Single-chain Probe Carrying Androgen Receptor N-Terminal Peptides. Analytical Sciences 25:12, pages 1415-1420.
Crossref
Raj Kumar & Gerald Litwack. (2009) Structural and functional relationships of the steroid hormone receptors’ N-terminal transactivation domain. Steroids 74:12, pages 877-883.
Crossref
Martin L. Privalsky, Sangho Lee, Johnnie B. Hahm, Briana M. Young, Rebecca N.G. Fong & Ivan H. Chan. (2009) The p160 Coactivator PAS-B Motif Stabilizes Nuclear Receptor Binding and Contributes to Isoform-specific Regulation by Thyroid Hormone Receptors. Journal of Biological Chemistry 284:29, pages 19554-19563.
Crossref
Eleanor F. Need, Howard I. Scher, Amelia A. Peters, Nicole L. Moore, Albert Cheong, Charles J. Ryan, Gary A. Wittert, Villis R. Marshall, Wayne D. Tilley & Grant Buchanan. (2009) A Novel Androgen Receptor Amino Terminal Region Reveals Two Classes of Amino/Carboxyl Interaction-Deficient Variants with Divergent Capacity to Activate Responsive Sites in Chromatin. Endocrinology 150:6, pages 2674-2682.
Crossref
Ni Ai, Matthew D. Krasowski, William J. Welsh & Sean Ekins. (2009) Understanding nuclear receptors using computational methods. Drug Discovery Today 14:9-10, pages 486-494.
Crossref
Qiuping Ma, Wei Fu, Pengfei Li, Santo V. Nicosia, Guido Jenster, Xiaohong Zhang & Wenlong Bai. (2009) FoxO1 Mediates PTEN Suppression of Androgen Receptor N- and C-Terminal Interactions and Coactivator Recruitment. Molecular Endocrinology 23:2, pages 213-225.
Crossref
Scott M. Dehm & Donald J. Tindall. 2009. Androgen Action in Prostate Cancer. Androgen Action in Prostate Cancer 427 449 .
Li Jia, Omar Khalid, Baruch Frenkel & Gerhard A. Coetzee. 2009. Androgen Action in Prostate Cancer. Androgen Action in Prostate Cancer 405 424 .
F. Claessens, T. Tanner & A. Haelens. 2009. Androgen Action in Prostate Cancer. Androgen Action in Prostate Cancer 385 404 .
Latif A. Wafa, Robert Snoek & Paul S. Rennie. 2009. Androgen Action in Prostate Cancer. Androgen Action in Prostate Cancer 341 374 .
Elizabeth M. Wilson. 2009. Androgen Action in Prostate Cancer. Androgen Action in Prostate Cancer 241 267 .
Grant Buchanan, Eleanor F. Need, Tina Bianco-Miotto, Norman M. Greenberg, Howard I. Scher, Margaret M. Centenera, Lisa M. Butler, Diane M. Robins & Wayne D. Tilley. 2009. Androgen Action in Prostate Cancer. Androgen Action in Prostate Cancer 207 240 .
Michael L. Mohler, Casey E. Bohl, Ramesh Narayanan, Yali He, Dong Jin Hwang, James T. Dalton & Duane D. Miller. 2008. Nuclear Receptors as Drug Targets. Nuclear Receptors as Drug Targets 249 304 .
Belen Vaz, Sabine Möcklinghoff & Luc Brunsveld. 2008. Nuclear Receptors as Drug Targets. Nuclear Receptors as Drug Targets 25 45 .
Scott M. Dehm, Lucy J. Schmidt, Hannelore V. Heemers, Robert L. Vessella & Donald J. Tindall. (2008) Splicing of a Novel Androgen Receptor Exon Generates a Constitutively Active Androgen Receptor that Mediates Prostate Cancer Therapy Resistance . Cancer Research 68:13, pages 5469-5477.
Crossref
Derek N. Lavery & Iain J. McEwan. (2008) Functional Characterization of the Native NH 2 -Terminal Transactivation Domain of the Human Androgen Receptor: Binding Kinetics for Interactions with TFIIF and SRC-1a . Biochemistry 47:11, pages 3352-3359.
Crossref
U.I. Mödder, A. Sanyal, J. Xu, B.W. O'Malley, T.C. Spelsberg & S. Khosla. (2008) The skeletal response to estrogen is impaired in female but not in male steroid receptor coactivator (SRC)-1 knock out mice. Bone 42:2, pages 414-421.
Crossref
Ramesh Narayanan, Michael L. Mohler, Casey E. Bohl, Duane D. Miller & James T. Dalton. (2008) Selective androgen receptor modulators in preclinical and clinical development. Nuclear Receptor Signaling 6:1, pages nrs.06010.
Crossref
Frank Claessens, Sarah Denayer, Nora Van Tilborgh, Stefanie Kerkhofs, Christine Helsen & Annemie Haelens. (2008) Diverse roles of androgen receptor (AR) domains in AR-mediated signaling. Nuclear Receptor Signaling 6:1, pages nrs.06008.
Crossref
Takeshi HOSOYA, Tsuyoshi MONDEN, Yoshitatsu FUKABORI, Koshi HASHIMOTO, Teturou SATOH, Kikuo KASAI, Masanobu YAMADA & Masatomo MORI. (2008) A Novel Splice Variant of the Nuclear Coactivator p120 Functions Strongly for Androgen Receptor: Characteristic Expression in Prostate Disease. Endocrine Journal 55:4, pages 657-665.
Crossref
Ji Ho Suh, Minho Shong, Hueng-Sik Choi & Keesook Lee. (2008) CR6-Interacting Factor 1 Represses the Transactivation of Androgen Receptor by Direct Interaction. Molecular Endocrinology 22:1, pages 33-46.
Crossref
RLYKA DRESNER-POLLAK, S. AUBREY STOCH & MICHAEL ROSENBLATT. 2008. Osteoporosis. Osteoporosis 1837 1895 .
Scott M. Dehm & Donald J. Tindall. (2007) Androgen Receptor Structural and Functional Elements: Role and Regulation in Prostate Cancer. Molecular Endocrinology 21:12, pages 2855-2863.
Crossref
Hannelore V. Heemers & Donald J. Tindall. (2007) Androgen Receptor (AR) Coregulators: A Diversity of Functions Converging on and Regulating the AR Transcriptional Complex. Endocrine Reviews 28:7, pages 778-808.
Crossref
Katia Margiotti, Latif A Wafa, Helen Cheng, Giuseppe Novelli, Colleen C Nelson & Paul S Rennie. (2007) Androgen-regulated genes differentially modulated by the androgen receptor coactivator L-dopa decarboxylase in human prostate cancer cells. Molecular Cancer 6:1.
Crossref
Scott M. Dehm, Kevin M. Regan, Lucy J. Schmidt & Donald J. Tindall. (2007) Selective Role of an NH2-Terminal WxxLF Motif for Aberrant Androgen Receptor Activation in Androgen Depletion–Independent Prostate Cancer Cells. Cancer Research 67:20, pages 10067-10077.
Crossref
Myles C. Hodgson, Inna Astapova, Anthony N. Hollenberg & Steven P. Balk. (2007) Activity of Androgen Receptor Antagonist Bicalutamide in Prostate Cancer Cells Is Independent of NCoR and SMRT Corepressors. Cancer Research 67:17, pages 8388-8395.
Crossref
Jan Trapman & Hendrikus Jan Dubbink. (2007) The role of cofactors in sex steroid action. Best Practice & Research Clinical Endocrinology & Metabolism 21:3, pages 403-414.
Crossref
Hiroo Nakauchi, Ken-ichi Matsuda, Ikuo Ochiai, Akihiro Kawauchi, Yoichi Mizutani, Tsuneharu Miki & Mitsuhiro Kawata. (2007) A Differential Ligand-mediated Response of Green Fluorescent Protein-tagged Androgen Receptor in Living Prostate Cancer and Non-prostate Cancer Cell Lines. Journal of Histochemistry & Cytochemistry 55:6, pages 535-544.
Crossref
Nupam P. MahajanYuanbo LiuSamarpan MajumderMaria R. WarrenCarol E. ParkerJames L. Mohler, H. Shelton Earp & Young E. Whang. (2007) Activated Cdc42-associated kinase Ack1 promotes prostate cancer progression via androgen receptor tyrosine phosphorylation. Proceedings of the National Academy of Sciences 104:20, pages 8438-8443.
Crossref
Udo Moehren, Maria Papaioannou, Christina A. Reeb, Wei Hong & Aria Baniahmad. (2007) Alien Interacts with the Human Androgen Receptor and Inhibits Prostate Cancer Cell Growth. Molecular Endocrinology 21:5, pages 1039-1048.
Crossref
Annemie Haelens, Tamzin Tanner, Sarah Denayer, Leen Callewaert & Frank Claessens. (2007) The Hinge Region Regulates DNA Binding, Nuclear Translocation, and Transactivation of the Androgen Receptor. Cancer Research 67:9, pages 4514-4523.
Crossref
Zhiming Yang, Yu-Jia Chang, Hiroshi Miyamoto, Shuyuan Yeh, Jorge L. Yao, P. Anthony di Sant’Agnese, Meng-Yin Tsai & Chawnshang Chang. (2007) Suppression of Androgen Receptor Transactivation and Prostate Cancer Cell Growth by Heterogeneous Nuclear Ribonucleoprotein A1 via Interaction with Androgen Receptor Coregulator ARA54. Endocrinology 148:3, pages 1340-1349.
Crossref
Zhiming YangYu-Jia ChangHiroshi MiyamotoJing NiYuanjie NiuZhaodian ChenYuh-Ling Chen, Jorge L. YaoP. Anthony di Sant’AgneseChawnshang Chang. (2007) Transgelin Functions as a Suppressor via Inhibition of ARA54-Enhanced Androgen Receptor Transactivation and Prostate Cancer Cell Growth. Molecular Endocrinology 21:2, pages 343-358.
Crossref
G. Verrijdt, T. Tanner, U. Moehren, L. Callewaert, A. Haelens & F. Claessens. (2006) The androgen receptor DNA-binding domain determines androgen selectivity of transcriptional response. Biochemical Society Transactions 34:6, pages 1089-1094.
Crossref
Jan-Hendrik Bebermeier, James D. Brooks, Samuel E. DePrimo, Ralf Werner, Uta Deppe, Janos Demeter, Olaf Hiort & Paul-Martin Holterhus. (2006) Cell-line and tissue-specific signatures of androgen receptor-coregulator transcription. Journal of Molecular Medicine 84:11, pages 919-931.
Crossref
Ulla Karvonen, Olli A. Jänne & Jorma J. Palvimo. (2006) Androgen receptor regulates nuclear trafficking and nuclear domain residency of corepressor HDAC7 in a ligand-dependent fashion. Experimental Cell Research 312:16, pages 3165-3183.
Crossref
Hanna E. Mäki, Kati K. Waltering, Mika J. Wallén, Paula M. Martikainen, Teuvo L.J. Tammela, Wytske M. van Weerden, Robert L. Vessella & Tapio Visakorpi. (2006) Screening of genetic and expression alterations of SRC1 gene in prostate cancer. The Prostate 66:13, pages 1391-1398.
Crossref
Ai-Hong Ma, Liang Xia, Sonal J. Desai, David L. Boucher, Yi Guan, Hsiu-Ming Shih, Xu-Bao Shi, Ralph W. deVere White, Hong-Wu Chen, Cliff G. Tepper & Hsing-Jien Kung. (2006) Male Germ Cell–Associated Kinase, a Male-Specific Kinase Regulated by Androgen, Is a Coactivator of Androgen Receptor in Prostate Cancer Cells. Cancer Research 66:17, pages 8439-8447.
Crossref
Scott M. Dehm & Donald J. Tindall. (2006) Ligand-independent Androgen Receptor Activity Is Activation Function-2-independent and Resistant to Antiandrogens in Androgen Refractory Prostate Cancer Cells. Journal of Biological Chemistry 281:38, pages 27882-27893.
Crossref
Jiwen LiJunjiang FuCharalambos ToumazouHo-Geun Yoon & Jiemin Wong. (2006) A Role of the Amino-Terminal (N) and Carboxyl-Terminal (C) Interaction in Binding of Androgen Receptor to Chromatin. Molecular Endocrinology 20:4, pages 776-785.
Crossref
Hironori Katoh, Yukiko Ogino & Gen Yamada. (2006) Cloning and expression analysis of androgen receptor gene in chicken embryogenesis. FEBS Letters 580:6, pages 1607-1615.
Crossref
Shuli Fan, Kiminobu Goto, Guangchun Chen, Hidetaka Morinaga, Masatoshi Nomura, Taijiro Okabe, Hajime Nawata & Toshihiko Yanase. (2006) Identification of the functional domains of ANT-1, a novel coactivator of the androgen receptor. Biochemical and Biophysical Research Communications 341:1, pages 192-201.
Crossref
Zhe Zheng, Changmeng Cai, Josephat Omwancha, Shao-Yong Chen, Timour Baslan & Lirim Shemshedini. (2006) SUMO-3 Enhances Androgen Receptor Transcriptional Activity through a Sumoylation-independent Mechanism in Prostate Cancer Cells. Journal of Biological Chemistry 281:7, pages 4002-4012.
Crossref
Ping Zhu, Sung Hee Baek, Eliot M. Bourk, Kenneth A. Ohgi, Ivan Garcia-Bassets, Hideki Sanjo, Shizuo Akira, Paul F. Kotol, Christopher K. Glass, Michael G. Rosenfeld & David W. Rose. (2006) Macrophage/Cancer Cell Interactions Mediate Hormone Resistance by a Nuclear Receptor Derepression Pathway. Cell 124:3, pages 615-629.
Crossref
Leen Callewaert, Nora Van Tilborgh & Frank Claessens. (2006) Interplay between Two Hormone-Independent Activation Domains in the Androgen Receptor. Cancer Research 66:1, pages 543-553.
Crossref
Fei Xiao, Andreas Mirwald, Maria Papaioannou, Aria Baniahmad & Jörg Klug. (2005) Secretoglobin 2A1 Is under Selective Androgen Control Mediated by a Peculiar Binding Site for Sp Family Transcription Factors. Molecular Endocrinology 19:12, pages 2964-2978.
Crossref
Derek N. LaveryIain J. Mcewan. (2005) Structure and function of steroid receptor AF1 transactivation domains: induction of active conformations. Biochemical Journal 391:3, pages 449-464.
Crossref
Irina U. Agoulnik, Ajula Vaid, William E. BingmanIIIIII, Halime Erdeme, Anna Frolov, Carolyn L. Smith, Gustavo Ayala, Michael M. Ittmann & Nancy L. Weigel. (2005) Role of SRC-1 in the Promotion of Prostate Cancer Cell Growth and Tumor Progression. Cancer Research 65:17, pages 7959-7967.
Crossref
Qianben Wang, Jason S. Carroll & Myles Brown. (2005) Spatial and Temporal Recruitment of Androgen Receptor and Its Coactivators Involves Chromosomal Looping and Polymerase Tracking. Molecular Cell 19:5, pages 631-642.
Crossref
Yuexing Zhang, Xin-Wei Wang, Danijela Jelovac, Takeo Nakanishi, Myoung-hee Yu, Damilola Akinmade, Olga Goloubeva, Douglas D. Ross, Angela Brodie & Anne W. Hamburger. (2005) The ErbB3-binding protein Ebp1 suppresses androgen receptor-mediated gene transcription and tumorigenesis of prostate cancer cells. Proceedings of the National Academy of Sciences 102:28, pages 9890-9895.
Crossref
Xiangcang Ye, Sang Jun Han, Sophia Y. Tsai, Francesco J. DeMayo, Jianming Xu, Ming-Jer Tsai & Bert W. O'Malley. (2005) Roles of steroid receptor coactivator (SRC)-1 and transcriptional intermediary factor (TIF) 2 in androgen receptor activity in mice. Proceedings of the National Academy of Sciences 102:27, pages 9487-9492.
Crossref
Guangchun Chen, Xiaohui Wang, Shimin Zhang, Ying Lu, Yinghao Sun, Jinshan Zhang, Zongbin Li & Jian Lu. (2005) Androgen receptor mutants detected in recurrent prostate cancer exhibit diverse functional characteristics. The Prostate 63:4, pages 395-406.
Crossref
Anniek Corveleyn, Hilde Janssen, Alessandra Martini, Riet Somers, Jan Cools & Peter Marynen. (2005) Cellular transformation of NIH3T3 fibroblasts by CIZ/NMP4 fusions. Journal of Cellular Biochemistry 94:6, pages 1112-1125.
Crossref
C. J. BurdC. E. PetreH. MoghadamE. M. Wilson & K. E. Knudsen. (2005) Cyclin D1 Binding to the Androgen Receptor (AR) NH2-Terminal Domain Inhibits Activation Function 2 Association and Reveals Dual Roles for AR Corepression. Molecular Endocrinology 19:3, pages 607-620.
Crossref
Sehyung Cho, Benjamin L. Kagan, John A. BlackfordJr.Jr., Daniele Szapary & S. Stoney SimonsJr.Jr.. (2005) Glucocorticoid Receptor Ligand Binding Domain Is Sufficient for the Modulation of Glucocorticoid Induction Properties by Homologous Receptors, Coactivator Transcription Intermediary Factor 2, and Ubc9. Molecular Endocrinology 19:2, pages 290-311.
Crossref
Myles C. Hodgson, Inna Astapova, Shinta Cheng, Larissa J. Lee, Manon C. Verhoeven, Eunis Choi, Steven P. Balk & Anthony N. Hollenberg. (2005) The Androgen Receptor Recruits Nuclear Receptor CoRepressor (N-CoR) in the Presence of Mifepristone via Its N and C Termini Revealing a Novel Molecular Mechanism for Androgen Receptor Antagonists. Journal of Biological Chemistry 280:8, pages 6511-6519.
Crossref
Dacheng Ding, Lihua Xu, Mani Menon, G. Prem Veer Reddy & Evelyn R. Barrack. (2005) Effect of GGC (glycine) repeat length polymorphism in the human androgen receptor on androgen action. The Prostate 62:2, pages 133-139.
Crossref
Jose D. Debes, Zoran Culig & Donald J. Tindall. 2005. Hormonal Carcinogenesis IV. Hormonal Carcinogenesis IV 494 500 .
David Masiello, Shao-Yong Chen, Youyuan Xu, Manon C. Verhoeven, Eunis Choi, Anthony N. Hollenberg & Steven P. Balk. (2004) Recruitment of β-Catenin by Wild-Type or Mutant Androgen Receptors Correlates with Ligand-Stimulated Growth of Prostate Cancer Cells. Molecular Endocrinology 18:10, pages 2388-2401.
Crossref
Charmian A. Quigley, Jiann-an Tan, Bin He, Zhong-xun Zhou, Farida Mebarki, Yves Morel, Maguelone G. Forest, Pierre Chatelain, E. Martin Ritzén, Frank S. French & Elizabeth M. Wilson. (2004) Partial androgen insensitivity with phenotypic variation caused by androgen receptor mutations that disrupt activation function 2 and the NH2- and carboxyl-terminal interaction. Mechanisms of Ageing and Development 125:10-11, pages 683-695.
Crossref
Hendrikus J. Dubbink, Remko Hersmus, Chandra S. Verma, Hetty A. G. M. van der Korput, Cor A. Berrevoets, Judith van Tol, Angelique C. J. Ziel-van der Made, Albert O. Brinkmann, Ashley C. W. Pike & Jan Trapman. (2004) Distinct Recognition Modes of FXXLF and LXXLL Motifs by the Androgen Receptor. Molecular Endocrinology 18:9, pages 2132-2150.
Crossref
Eugene Hur, Samuel J Pfaff, E. Sturgis Payne, Hanne Grøn, Benjamin M Buehrer & Robert J Fletterick. (2004) Recognition and Accommodation at the Androgen Receptor Coactivator Binding Interface. PLoS Biology 2:9, pages e274.
Crossref
Rile Li, Thomas Wheeler, Hong Dai, Anna Frolov, Timothy Thompson & Gustavo Ayala. (2004) High Level of Androgen Receptor Is Associated With Aggressive Clinicopathologic Features and Decreased Biochemical Recurrence-free Survival in Prostate. The American Journal of Surgical Pathology 28:7, pages 928-934.
Crossref
Maofu Fu, Mahadev Rao, Kongming Wu, Chenguang Wang, Xueping Zhang, Mohamed Hessien, Yee-Guide Yeung, Daniel Gioeli, Michael J. Weber & Richard G. Pestell. (2004) The Androgen Receptor Acetylation Site Regulates cAMP and AKT but Not ERK-induced Activity. Journal of Biological Chemistry 279:28, pages 29436-29449.
Crossref
Hyun Duk Jang, Kwiyeom Yoon, Young Joo Shin, Jaesang Kim & Soo Young Lee. (2004) PIAS3 Suppresses NF-κB-mediated Transcription by Interacting with the p65/RelA Subunit. Journal of Biological Chemistry 279:23, pages 24873-24880.
Crossref
Ben E. Black, Michael J. Vitto, Daniel Gioeli, Adam Spencer, Nima Afshar, Mark R. Conaway, Michael J. Weber & Bryce M. Paschal. (2004) Transient, Ligand-Dependent Arrest of the Androgen Receptor in Subnuclear Foci Alters Phosphorylation and Coactivator Interactions. Molecular Endocrinology 18:4, pages 834-850.
Crossref
Qianben Wang, T.S. Udayakumar, Tadas S. Vasaitis, Angela M. Brodie & Joseph D. Fondell. (2004) Mechanistic Relationship between Androgen Receptor Polyglutamine Tract Truncation and Androgen-dependent Transcriptional Hyperactivity in Prostate Cancer Cells. Journal of Biological Chemistry 279:17, pages 17319-17328.
Crossref
Shinta Cheng & Steven P. Balk. 2004. Signal Transduction in Cancer. Signal Transduction in Cancer 293 318 .
James Thompson, Katriina J Peltola, Päivi J Koskinen, Olli A Jänne & Jorma J Palvimo. (2003) Attenuation of Androgen Receptor-Dependent Transcription by the Serine/Threonine Kinase Pim-1. Laboratory Investigation 83:9, pages 1301-1309.
Crossref
Ken Ishitani, Tasuku Yoshida, Hirochika Kitagawa, Hiroaki Ohta, Shiro Nozawa & Shigeaki Kato. (2003) p54nrb acts as a transcriptional coactivator for activation function 1 of the human androgen receptor. Biochemical and Biophysical Research Communications 306:3, pages 660-665.
Crossref
Maofu Fu, Chenguang Wang, Xueping Zhang & Richard Pestell. (2003) Nuclear receptor modifications and endocrine cell proliferation. The Journal of Steroid Biochemistry and Molecular Biology 85:2-5, pages 133-138.
Crossref
Leen Callewaert, Valerie Christiaens, Annemie Haelens, Guy Verrijdt, Guido Verhoeven & Frank Claessens. (2003) Implications of a polyglutamine tract in the function of the human androgen receptor. Biochemical and Biophysical Research Communications 306:1, pages 46-52.
Crossref
Veerle Janssens, Jan Jordens, Ilse Stevens, Christine Van Hoof, Ellen Martens, Humbert De Smedt, Yves Engelborghs, Etienne Waelkens & Jozef Goris. (2003) Identification and Functional Analysis of Two Ca2+-binding EF-hand Motifs in the B“/PR72 Subunit of Protein Phosphatase 2A. Journal of Biological Chemistry 278:12, pages 10697-10706.
Crossref
Leen Callewaert, Guy Verrijdt, Valerie Christiaens, Annemie Haelens & Frank Claessens. (2003) Dual Function of an Amino-terminal Amphipatic Helix in Androgen Receptor-mediated Transactivation through Specific and Nonspecific Response Elements. Journal of Biological Chemistry 278:10, pages 8212-8218.
Crossref
T.M. Tanner, G. Verrijdt, W. Rombauts, A. Louw, J.P. Hapgood & F. Claessens. (2003) Anti-androgenic properties of Compound A, an analog of a non-steroidal plant compound. Molecular and Cellular Endocrinology 201:1-2, pages 155-164.
Crossref
Guoqing Liao, Liuh-Yow Chen, Aihua Zhang, Aparna Godavarthy, Fang Xia, Jagadish Chandra Ghosh, Hui Li & J. Don Chen. (2003) Regulation of Androgen Receptor Activity by the Nuclear Receptor Corepressor SMRT. Journal of Biological Chemistry 278:7, pages 5052-5061.
Crossref
Raj Kumar & E. Brad Thompson. (2003) Transactivation Functions of the N-Terminal Domains of Nuclear Hormone Receptors: Protein Folding and Coactivator Interactions. Molecular Endocrinology 17:1, pages 1-10.
Crossref
Marco Marcelli, Dolores J. Lamb, Nancy L. Weigel & Glenn R. Cunningham. 2003. Androgens in Health and Disease. Androgens in Health and Disease 157 189 .
Terry R. Brown. 2003. Androgens in Health and Disease. Androgens in Health and Disease 23 44 .
Valerie Christiaens, Charlotte L. Bevan, Leen Callewaert, Anna Haelens, Guy Verrijdt, Wilfried Rombauts & Frank Claessens. (2002) Characterization of the Two Coactivator-interacting Surfaces of the Androgen Receptor and Their Relative Role in Transcriptional Control*. Journal of Biological Chemistry 277:51, pages 49230-49237.
Crossref
Karine Steketee, Cor A Berrevoets, Hendrikus J. Dubbink, Paul Doesburg, Remko Hersmus, Albert O. Brinkmann & Jan Trapman. (2002) Amino acids 3-13 and amino acids in and flanking the 23 FxxLF 27 motif modulate the interaction between the N-terminal and ligand-binding domain of the androgen receptor . European Journal of Biochemistry 269:23, pages 5780-5791.
Crossref
Maria Papaioannou, Thomas Ruppert, Helmut Dotzlaw, Uwe Dressel & Aria Baniahmad. (2002) Protein–protein cross-linking in the use of the eukaryotic eGST-fusion system. Protein Expression and Purification 26:3, pages 462-466.
Crossref
Qianben Wang, Dipali Sharma, Yunsheng Ren & Joseph D. Fondell. (2002) A Coregulatory Role for the TRAP-Mediator Complex in Androgen Receptor-mediated Gene Expression. Journal of Biological Chemistry 277:45, pages 42852-42858.
Crossref
James Reid, Ian Murray, Kate Watt, Russell Betney & Iain J. McEwan. (2002) The Androgen Receptor Interacts with Multiple Regions of the Large Subunit of General Transcription Factor TFIIF. Journal of Biological Chemistry 277:43, pages 41247-41253.
Crossref
Peng Li, Xin Yu, Kai Ge, Jonathan Melamed, Robert G. Roeder & Zhengxin Wang. (2002) Heterogeneous Expression and Functions of Androgen Receptor Co-Factors in Primary Prostate Cancer. The American Journal of Pathology 161:4, pages 1467-1474.
Crossref
Guy Verrijdt, Kris Schauwaers, Annemie Haelens, Wilfried Rombauts & Frank Claessens. (2002) Functional Interplay between Two Response Elements with Distinct Binding Characteristics Dictates Androgen Specificity of the Mouse Sex-limited Protein Enhancer. Journal of Biological Chemistry 277:38, pages 35191-35201.
Crossref
Steven P Balk. (2002) Androgen receptor as a target in androgen-independent prostate cancer. Urology 60:3, pages 132-138.
Crossref
Yuexing Zhang, Joseph D Fondell, Qianben Wang, Xianmin Xia, Aiwu Cheng, Michael L Lu & Anne W Hamburger. (2002) Repression of androgen receptor mediated transcription by the ErbB-3 binding protein, Ebp1. Oncogene 21:36, pages 5609-5618.
Crossref
Angeliki Magklara, Theodore J. Brown & Eleftherios P. Diamandis. (2002) Characterization of androgen receptor and nuclear receptor co-regulator expression in human breast cancer cell lines exhibiting differential regulation of kallikreins 2 and 3. International Journal of Cancer 100:5, pages 507-514.
Crossref
Yue Zhao, Kiminobu Goto, Masayuki Saitoh, Toshihiko Yanase, Masatoshi Nomura, Taijiro Okabe, Ryoichi Takayanagi & Hajime Nawata. (2002) Activation Function-1 Domain of Androgen Receptor Contributes to the Interaction between Subnuclear Splicing Factor Compartment and Nuclear Receptor Compartment. Journal of Biological Chemistry 277:33, pages 30031-30039.
Crossref
U Karvonen, O.A Jänne & J.J Palvimo. (2002) Pure antiandrogens disrupt the recruitment of coactivator GRIP1 to colocalize with androgen receptor in nuclei. FEBS Letters 523:1-3, pages 43-47.
Crossref
Shinta Cheng, Sabrina Brzostek, Suzanne R. Lee, Anthony N. Hollenberg & Steven P. Balk. (2002) Inhibition of the Dihydrotestosterone-Activated Androgen Receptor by Nuclear Receptor Corepressor. Molecular Endocrinology 16:7, pages 1492-1501.
Crossref
Edward P. Gelmann. (2002) Molecular Biology of the Androgen Receptor. Journal of Clinical Oncology 20:13, pages 3001-3015.
Crossref
David Masiello, Shinta Cheng, Glenn J. Bubley, Michael L. Lu & Steven P. Balk. (2002) Bicalutamide Functions as an Androgen Receptor Antagonist by Assembly of a Transcriptionally Inactive Receptor. Journal of Biological Chemistry 277:29, pages 26321-26326.
Crossref
Bin He, Lori W. Lee, John T. Minges & Elizabeth M. Wilson. (2002) Dependence of Selective Gene Activation on the Androgen Receptor NH2- and COOH-terminal Interaction. Journal of Biological Chemistry 277:28, pages 25631-25639.
Crossref
Paola Ferro, Maria G. Catalano, Raffaella Dell'Eva, Nicoletta Fortunati & Ulrich Pfeffer. (2002) The androgen receptor CAG repeat: a modifier of carcinogenesis?. Molecular and Cellular Endocrinology 193:1-2, pages 109-120.
Crossref
James Reid, Sharon M. Kelly, Kate Watt, Nicholas C. Price & Iain J. McEwan. (2002) Conformational Analysis of the Androgen Receptor Amino-terminal Domain Involved in Transactivation. Journal of Biological Chemistry 277:22, pages 20079-20086.
Crossref
Jiann-An Tan, Susan H. Hall, Katherine G. Hamil, Gail Grossman, Peter Petrusz & Frank S. French. (2002) Protein Inhibitors of Activated STAT Resemble Scaffold Attachment Factors and Function as Interacting Nuclear Receptor Coregulators. Journal of Biological Chemistry 277:19, pages 16993-17001.
Crossref
Masayuki Saitoh, Ryoichi Takayanagi, Kiminobu Goto, Akiyoshi Fukamizu, Arihiro Tomura, Toshihiko Yanase & Hajime Nawata. (2002) The Presence of Both the Amino- and Carboxyl-Terminal Domains in the AR Is Essential for the Completion of a Transcriptionally Active Form with Coactivators and Intranuclear Compartmentalization Common to the Steroid Hormone Receptors: A Three-Dimensional Imaging Study. Molecular Endocrinology 16:4, pages 694-706.
Crossref
Helmut Dotzlaw, Udo Moehren, Sigrun Mink, Andrew C. B. Cato, Jorge A. Iñiguez Lluhí & Aria Baniahmad. (2002) The Amino Terminus of the Human AR Is Target for Corepressor Action and Antihormone Agonism. Molecular Endocrinology 16:4, pages 661-673.
Crossref
Cynthia A. Heinlein & Chawnshang Chang. (2002) Androgen Receptor (AR) Coregulators: An Overview. Endocrine Reviews 23:2, pages 175-200.
Crossref
Sunil Kaul, John A. BlackfordJr.Jr., Sehyung Cho & S. Stoney SimonsJr.Jr.. (2002) Ubc9 Is a Novel Modulator of the Induction Properties of Glucocorticoid Receptors. Journal of Biological Chemistry 277:15, pages 12541-12549.
Crossref
Zhong-xun Zhou, Bin He, Susan H. Hall, Elizabeth M. Wilson & Frank S. French. (2002) Domain Interactions between Coregulator ARA70 and the Androgen Receptor (AR). Molecular Endocrinology 16:2, pages 287-300.
Crossref
Steven M. Markus, Samir S. Taneja, Susan K. Logan, Wenhui Li, Susan Ha, Adam B. Hittelman, Inez Rogatsky & Michael J. Garabedian. (2002) Identification and Characterization of ART-27, a Novel Coactivator for the Androgen Receptor N Terminus. Molecular Biology of the Cell 13:2, pages 670-682.
Crossref
Huei-Ju Ting, Shuyuan Yeh, Kazuo Nishimura & Chawnshang Chang. (2002) Supervillin associates with androgen receptor and modulates its transcriptional activity. Proceedings of the National Academy of Sciences 99:2, pages 661-666.
Crossref
Suzanne R. Lee, Sharon M. Ramos, Andrew Ko, David Masiello, Kenneth D. Swanson, Michael L. Lu & Steven P. Balk. (2002) AR and ER Interaction with a p21-Activated Kinase (PAK6). Molecular Endocrinology 16:1, pages 85-99.
Crossref
Pierre Germain, Jaya Iyer, Christina Zechel & Hinrich Gronemeyer. (2002) Co-regulator recruitment and the mechanism of retinoic acid receptor synergy. Nature 415:6868, pages 187-192.
Crossref
Peng Lee & Zhengxin Wang. 2002. Molecular Pathology, Colorectal Carcinoma, and Prostate Carcinoma. Molecular Pathology, Colorectal Carcinoma, and Prostate Carcinoma 409 422 .
Jessica L Walcott & Diane E Merry. 2002. 127 147 .
Vincent Laudet & Hinrich Gronemeyer. 2002. The Nuclear Receptor FactsBook. The Nuclear Receptor FactsBook 391 400 .
Vincent Laudet & Hinrich Gronemeyer. 2002. The Nuclear Receptor FactsBook. The Nuclear Receptor FactsBook 42 61 .
Azriel Schmidt, Shun-ichi Harada & Gideon A. Rodan. 2002. Principles of Bone Biology. Principles of Bone Biology 1455 1466 .
William Bourguet, Pierre Germain & Hinrich Gronemeyer. 2002. Hormone Signaling. Hormone Signaling 241 267 .
Terry R. Brown. 2002. Androgens and Androgen Receptor. Androgens and Androgen Receptor 213 243 .
Cynthia A. Heinlein, Erik R. Sampson & Chawnshang Chang. 2002. Androgens and Androgen Receptor. Androgens and Androgen Receptor 91 138 .
Xin Yuan, Michael L. Lu, Tong Li & Steven P. Balk. (2001) SRY Interacts with and Negatively Regulates Androgen Receptor Transcriptional Activity. Journal of Biological Chemistry 276:49, pages 46647-46654.
Crossref
Anette Wärnmark, Anja Wikström, Anthony P.H. Wright, Jan-Åke Gustafsson & Torleif Härd. (2001) The N-terminal Regions of Estrogen Receptor α and β Are Unstructured in Vitro and Show Different TBP Binding Properties. Journal of Biological Chemistry 276:49, pages 45939-45944.
Crossref
Luke Gaughan, Mark E. Brady, Susan Cook, David E. Neal & Craig N. Robson. (2001) Tip60 Is a Co-activator Specific for Class I Nuclear Hormone Receptors. Journal of Biological Chemistry 276:50, pages 46841-46848.
Crossref
M. E. Grossmann, H. Huang & D. J. Tindall. (2001) Androgen Receptor Signaling in Androgen-Refractory Prostate Cancer. JNCI Journal of the National Cancer Institute 93:22, pages 1687-1697.
Crossref
Bin He, Natalie T. Bowen, John T. Minges & Elizabeth M. Wilson. (2001) Androgen-induced NH2- and COOH-terminal Interaction Inhibits p160 Coactivator Recruitment by Activation Function 2. Journal of Biological Chemistry 276:45, pages 42293-42301.
Crossref
Athanasios Bubulya, Shao-Yong Chen, Christopher J. Fisher, Zhe Zheng, Xi-Qiang Shen & Lirim Shemshedini. (2001) c-Jun Potentiates the Functional Interaction between the Amino and Carboxyl Termini of the Androgen Receptor. Journal of Biological Chemistry 276:48, pages 44704-44711.
Crossref
Jennifer L. Shenk, Christopher J. Fisher, Shao-Yong Chen, Xiao-Feng Zhou, Karl Tillman & Lirim Shemshedini. (2001) p53 Represses Androgen-induced Transactivation of Prostate-specific Antigen by Disrupting hAR Amino- to Carboxyl-terminal Interaction. Journal of Biological Chemistry 276:42, pages 38472-38479.
Crossref
Raja Dey, P. Roychowdhury & C. Mukherjee. (2001) Homology modelling of the ligand-binding domain of glucocorticoid receptor: binding site interactions with cortisol and corticosterone. Protein Engineering, Design and Selection 14:8, pages 565-571.
Crossref
Thomas Slagsvold, Irene Kraus, Katrine Frønsdal & Fahri Saatcioglu. (2001) DNA Binding-independent Transcriptional Activation by the Androgen Receptor through Triggering of Coactivators. Journal of Biological Chemistry 276:33, pages 31030-31036.
Crossref
Zhihong Yang & Martin L. Privalsky. (2001) Isoform-Specific Transcriptional Regulation by Thyroid Hormone Receptors: Hormone-Independent Activation Operates through a Steroid Receptor Mode of Coactivator Interaction. Molecular Endocrinology 15:7, pages 1170-1185.
Crossref
Ana Aranda & Angel Pascual. (2001) Nuclear Hormone Receptors and Gene Expression. Physiological Reviews 81:3, pages 1269-1304.
Crossref
Lars Brive, David B. Agus & Kathryn R. Ely. (2002) Structure-Based Androgen Receptor Gene Mutation Database: A Tool to Link Molecular Location and Receptor Function. The Prostate Journal 3:2, pages 76-91.
Crossref
Jennifer M. GradLeah S. LyonsDiane M. Robins & Kerry L. Burnstein. (2001) The Androgen Receptor (AR) Amino-Terminus Imposes Androgen-Specific Regulation of AR Gene Expression via an Exonic Enhancer*. Endocrinology 142:3, pages 1107-1116.
Crossref
Qi Wang, JinHua Lu & E.L. Yong. (2001) Ligand- and Coactivator-mediated Transactivation Function (AF2) of the Androgen Receptor Ligand-binding Domain Is Inhibited by the Cognate Hinge Region. Journal of Biological Chemistry 276:10, pages 7493-7499.
Crossref
M. Ivelisse Gonzalez & Diane M. Robins. (2001) Oct-1 Preferentially Interacts with Androgen Receptor in a DNA-dependent Manner That Facilitates Recruitment of SRC-1. Journal of Biological Chemistry 276:9, pages 6420-6428.
Crossref
F. Claessens, G. Verrijdt, E. Schoenmakers, A. Haelens, B. Peeters, G. Verhoeven & W. Rombauts. (2001) Selective DNA binding by the androgen receptor as a mechanism for hormone-specific gene regulation. The Journal of Steroid Biochemistry and Molecular Biology 76:1-5, pages 23-30.
Crossref
Qianben Wang & Joseph D. Fondell. (2001) Generation of a Mammalian Cell Line Stably Expressing a Tetracycline-Regulated Epitope-Tagged Human Androgen Receptor: Implications for Steroid Hormone Receptor Research. Analytical Biochemistry 289:2, pages 217-230.
Crossref
Liang-Nian Song, Barbara Huse, Sandro Rusconi & S. Stoney SimonsJr.Jr.. (2001) Transactivation Specificity of Glucocorticoid VersusProgesterone Receptors. Journal of Biological Chemistry 276:27, pages 24806-24816.
Crossref
Noora Kotaja, Saara Aittomäki, Olli Silvennoinen, Jorma J. Palvimo & Olli A. Jänne. (2000) ARIP3 (Androgen Receptor-Interacting Protein 3) and Other PIAS (Protein Inhibitor of Activated STAT) Proteins Differ in Their Ability to Modulate Steroid Receptor-Dependent Transcriptional Activation. Molecular Endocrinology 14:12, pages 1986-2000.
Crossref
Joyce Lim, Farid J. Ghadessy, Abdullah A. R. Abdullah, Leonard Pinsky, Mark Trifiro & E. L. Yong. (2000) Human Androgen Receptor Mutation Disrupts Ternary Interactions between Ligand, Receptor Domains, and the Coactivator TIF2 (Transcription Intermediary Factor 2). Molecular Endocrinology 14:8, pages 1187-1197.
Crossref
Arndt Benecke, Pierre Chambon & Hinrich Gronemeyer. (2000) Synergy between estrogen receptor α activation functions AF1 and AF2 mediated by transcription intermediary factor TIF2. EMBO reports 1:2, pages 151-157.
Crossref
Bin He, Jon A. Kemppainen & Elizabeth M. Wilson. (2000) FXXLF and WXXLF Sequences Mediate the NH2-terminal Interaction with the Ligand Binding Domain of the Androgen Receptor. Journal of Biological Chemistry 275:30, pages 22986-22994.
Crossref
Guy Verrijdt, Erik Schoenmakers, Annemie Haelens, Ben Peeters, Guido Verhoeven, Wilfried Rombauts & Frank Claessens. (2000) Change of Specificity Mutations in Androgen-selective Enhancers. Journal of Biological Chemistry 275:16, pages 12298-12305.
Crossref
Erik Schoenmakers, Guy Verrijdt, Ben Peeters, Guido Verhoeven, Wilfried Rombauts & Frank Claessens. (2000) Differences in DNA Binding Characteristics of the Androgen and Glucocorticoid Receptors Can Determine Hormone-specific Responses. Journal of Biological Chemistry 275:16, pages 12290-12297.
Crossref
Christopher Leo & J.Don Chen. (2000) The SRC family of nuclear receptor coactivators. Gene 245:1, pages 1-11.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.